Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited Share · INE624Z01016 (XBOM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Solara Active Pharma Sciences Limited
No Price
Closing Price XBOM 30.04.2026: 499,50 INR
30.04.2026 10:00
Current Prices from Solara Active Pharma Sciences Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
SOLARA.NS
INR
30.04.2026 10:00
502,00 INR
11,25 INR
+2,29 %
XBOM: MSE
MSE
SOLARA.BO
INR
30.04.2026 09:59
499,50 INR
8,75 INR
+1,78 %
Share Float & Liquidity
Free Float 43,47 %
Shares Float 20,94 M
Shares Outstanding 48,17 M
Company Profile for Solara Active Pharma Sciences Limited Share
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, loop diuretic, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, topical anti-infectives, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, nucleoside inhibitor, aprepitant, NSAIDs, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company also exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Company Data

Name Solara Active Pharma Sciences Limited
Company Solara Active Pharma Sciences Limited
Website https://www.solara.co.in
Primary Exchange XBOM MSE
ISIN INE624Z01016
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Sandeep Shashikantha Rao PGDM
Market Capitalization 24 Mrd.
Country India
Currency INR
Employees 2,2 T
Address Admin Block 27, 600127 Chennai
IPO Date 2018-06-27
Dividends from 'Solara Active Pharma Sciences Limited'
Ex-Date Dividend per Share
18.08.2021 3,00 INR
19.11.2020 4,00 INR
28.07.2020 2,00 INR
06.08.2019 5,00 INR

Stock Splits

Date Split
15.05.2024 217:200

Ticker Symbols

Name Symbol
MSE SOLARA.BO
NSE SOLARA.NS
More Shares
Investors who hold Solara Active Pharma Sciences Limited also have the following shares in their portfolio:
LB.HESS.THR.CARRARA11L/24
LB.HESS.THR.CARRARA11L/24 Bond
The Hash Corporation
The Hash Corporation Share